Suggestions
Alastair Hick
Chief Commercialisation Officer at Monash University
Alastair Hick is a highly experienced professional in research and technology commercialization, currently serving as a Director at BioCurate Pty Ltd.34 His extensive career spans over 20 years in the field, with a strong focus on translating academic research into commercial applications.
Professional Background
Current Roles
- Chief Commercialisation Officer at Monash University (since April 2022)2
- Director at BioCurate Pty Ltd3
- Director at Jupiter Ionics and PIOtx2
Previous Positions
- Senior Director and Director of Monash Innovation at Monash University (2007-2022)2
- Chair of Knowledge Commercialisation Australasia (2015-2018)2
- Director at Amaero International Limited (2013-2019)2
- Head of Life Sciences at Cambridge Enterprise (2002-2006)2
Education and Qualifications
Alastair Hick holds several advanced degrees and professional qualifications:
- PhD in Chemical Ecology1
- MBA from the Judge Business School, University of Cambridge2
- BSc (Hons) in Chemistry with Biochemistry from the University of Southampton2
- Graduate of the Australian Institute of Company Directors (GAICD)2
Expertise and Contributions
Dr. Hick is recognized for his expertise in:
- Research and technology commercialization
- Developing successful licensing and spin-out programs
- Managing proof of concept funds and strategic partnerships with investors
- Overseeing entrepreneurship programs in academic settings
His contributions to the field have been acknowledged through his inclusion in the IAM Strategy 300: The World's Leading IP Strategists in 2020 and 2021.2
Professional Affiliations
Alastair Hick has been involved with several professional organizations:
- Member of the National Health and Medical Research Council's Health Research Impact Committee2
- Former member of the IP Australia Stakeholders Forum1
- Investment Committee Member for the Trans Tasman Commercialisation Fund2
Through his various roles and extensive experience, Alastair Hick has made significant contributions to bridging the gap between academic research and commercial applications in Australia and internationally.
Highlights
News just out today: A new wearable device ‘MiEye’ is a gamechanger for people with disrupted sleep. Developed by Monash University researchers and licensed through Monash Innovation to Circadian Health Innovations, the sensor is the brainchild of circadian biology experts Professor Sean W. Cain (Adjunct) and Associate Professor Andrew J. K. Phillips (Adjunct) from Monash Medicine, Nursing and Health Sciences.
Even better, Circadian Health Innovations is a spin-off company founded by the lead researchers after they completed The Accelerator program at Monash University’s start up hub, Monash Generator. Read more here #MonashInnovation #MonashEnterprise
https://lnkd.in/g9xCNKvf
ElectraLith, a Monash University spinout, has delivered proof of concept that its Direct Lithium Extraction and Refining (DLE-R) technology can produce battery grade lithium hydroxide from a range of lithium sources using no water, no chemicals and minimal energy. Backed by investment from Rio Tinto, IP Group plc and Monash Investment Holdings, ElectraLith’s DLE-R technology is unlocking a green future and emerging as the cleanest, most versatile and cost-efficient method for extracting and refining lithium, the fundamental element driving a sustainable future.
Read more https://lnkd.in/gp-CykJV #MonashEnterprise #MonashInnovation Charlie McGill Huanting Wang Professor Doron Ben-Meir Yiannis Ventikos FREng MA PhD Monash Engineering
